Bone and joint involvement in Fabry disease.

about

Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B.Pitfalls in Diagnosing Neuraminidase Deficiency: Psychosomatics and Normal Sialic Acid Excretion.

P2860

Q34311272-1B52F991-2DFD-4D74-88DB-B5B9047E1EB7 Q41427708-5B873471-987C-4F61-B48A-A22511DD5FE3

P2860

Bone and joint involvement in Fabry disease.

Item

http://www.wikidata.org/entity/Q42642413

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Bone and joint involvement in Fabry disease.

@en

Bone and joint involvement in Fabry disease.

@nl

type

Item

label

Bone and joint involvement in Fabry disease.

@en

Bone and joint involvement in Fabry disease.

@nl

prefLabel

Bone and joint involvement in Fabry disease.

@en

Bone and joint involvement in Fabry disease.

@nl

P1476

Bone and joint involvement in Fabry disease.

@en

P2093

B Giroux Leprieur

http://www.w3.org/2001/XMLSchema#string

C Caillaud

http://www.w3.org/2001/XMLSchema#string

J Laganier

http://www.w3.org/2001/XMLSchema#string

K Sacre

http://www.w3.org/2001/XMLSchema#string

N Ouali

http://www.w3.org/2001/XMLSchema#string

Olivier Lidove

http://www.w3.org/2001/XMLSchema#string

T Papo

http://www.w3.org/2001/XMLSchema#string

P2860

Avascular necrosis of the femoral head in a patient with Fabry's disease: identification of ceramide trihexoside in the bone by delayed-extraction matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.

Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy.

Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation.

Clinical practice. Osteoporosis in men.

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy.

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.

Effect of antiepileptic drugs on bone density in ambulatory patients.

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

Bone density in Type 1 Gaucher disease.

P304

171-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/03009740903270631

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40679699

http://www.w3.org/2001/XMLSchema#string

P698

20001766

http://www.w3.org/2001/XMLSchema#string

Bone and joint involvement in Fabry disease.

about

P2860

P2860

Bone and joint involvement in Fabry disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698